Gwang-Cheol Park
Director Ejecutivo en Premierbio Co., Ltd. .
Cargos activos de Gwang-Cheol Park
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Premierbio Co., Ltd.
 Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Director Ejecutivo | - | - |
Historial de carrera de Gwang-Cheol Park
Antiguos cargos conocidos de Gwang-Cheol Park.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DSK CO., LTD. | Director Ejecutivo | 30/03/2016 | - |
| Presidente | 30/03/2016 | - | |
| HYUNDAI SECURITIES CO LTD | Director/Miembro de la Junta | 21/06/2010 | - |
| Independent Dir/Board Member | 21/06/2010 | - |
Formación de Gwang-Cheol Park.
| Konkuk University | Doctorate Degree |
Estadísticas
Internacional
| Corea del Sur | 5 |
Operativa
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Finance | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DSK CO., LTD. | Electronic Technology |
| Empresas privadas | 2 |
|---|---|
KB Securities Co., Ltd
 KB Securities Co., Ltd Investment ManagersFinance KB Securities Co., Ltd (KB Securities) is a private equity subsidiary of KB Financial Group, Inc. founded in 1962. The firm is headquartered in Seoul, South Korea. | Finance |
Premierbio Co., Ltd.
Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Gwang-Cheol Park
- Experiencia
